CJC 129(without DAC)(CND)

What is CJC-1295 (Without DAC)?

CJC-1295 No DAC, often referred to by the abbreviation CND or Modified GRF 1-29, is a synthetic analog of the naturally occurring Growth Hormone Releasing Hormone (GHRH). It consists of the first 29 amino acids of GHRH, with four specific substitutions that significantly enhance its stability and resistance to enzymatic degradation. Unlike the “With DAC” version, which creates a long-lasting elevation of growth hormone levels, the No DAC version is designed to mimic the body’s natural, pulsatile release of GH. Consequently, researchers in the UK, USA, and Australia favor this peptide for its physiological approach to growth hormone stimulation.

Mechanism: Pulsatile Growth Hormone Secretion

The primary function of CJC-1295 No DAC is to bind to GHRH receptors in the anterior pituitary gland. By doing so, it triggers the release of stored growth hormone into the bloodstream. Because this version lacks the “Drug Affinity Complex” (DAC), it has a much shorter half-life—approximately 30 minutes. This allows for rapid, acute “spikes” in GH levels, which more closely resembles the natural circadian rhythms of human biology. Therefore, it is a primary research tool in Germany and France for studying the effects of GH pulses on tissue repair and metabolic function.

Synergistic Potential with GHRPs

In clinical science, CJC-1295 No DAC is frequently studied in combination with Growth Hormone Releasing Peptides (GHRPs), such as Ipamorelin or GHRP-6. While GHRH analogs like CJC-1295 act as the “accelerator” for GH release, GHRPs act by suppressing somatostatin (the “brake”). When used together, they produce a synergistic effect that results in a significantly larger pulse of growth hormone than either peptide could produce alone. Researchers in the USA and Spain prioritize this combination for investigating maximal recovery, lean muscle preservation, and cellular rejuvenation.

Physical Benefits and Recovery Research

Research into CJC-1295 No DAC has highlighted its potential for enhancing physical performance and recovery. By elevating endogenous growth hormone, the peptide promotes protein synthesis, encourages lipolysis (fat loss), and improves bone density. Furthermore, it has been observed to support deeper, more restorative stages of sleep, which is critical for systemic repair. Consequently, biotech firms in Australia and the UK utilize the compound to explore treatments for age-related muscle loss (sarcopenia) and the acceleration of injury rehabilitation in sports medicine.

Global Sourcing and Laboratory Standards Of CJC-1295 No DAC

For professional research in Spain, Germany, and the UK, maintaining chemical purity is essential for accurate and reproducible results. High-quality CJC-1295 No DAC is typically provided in a lyophilized state with a purity level exceeding 98%. To ensure the molecular integrity of the peptide, you must store the vials in a refrigerated environment between 2°C and 8°C. Once reconstituted with bacteriostatic or sterile water, the solution should be handled gently and used within its stability window. Following these strict protocols ensures that researchers can safely explore the metabolic and regenerative frontiers of GHRH therapy.